← Leaderboards
Anne Fagan Niven
Washington University
$12,288,829
Attributed
$12,288,829
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,288,829 · 13
By mechanism
P01$5,340,982 · 5
U19$4,565,686 · 3
UF1$842,932 · 1
P50$839,913 · 1
K01$280,656 · 1
U01$265,660 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Scott J Hultgren$48,876,558
- John Morris$91,785,862
- Thalachallour Mohanakumar$18,846,664
- Jennifer Alexander-Brett$4,133,766
- Rodney D Newberry$20,614,090
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseTau ProteinsImpaired CognitionLiquid SubstancePlasmaSamplingSymptomsPre-ClinicalCerebrospinal FluidBaseCohortBiological MarkersPathologyFutureParticipantBrainClinical TrialsHigh RiskMonitorPreventDementiaResearch PersonnelStaging
Grant awards (48)
Dominantly Inherited Alzheimer Network: Biomarker Core$439,276
U19 · FY2023 · AG · contact PI
Dominantly Inherited Alzheimer Network: Project 3$387,974
U19 · FY2023 · AG · contact PI
Dominantly Inherited Alzheimer Network: Project 3$468,629
U19 · FY2022 · AG · contact PI
Dominantly Inherited Alzheimer Network: Biomarker Core$409,284
U19 · FY2022 · AG · contact PI
Plasma and CSF Biomarkers that Predict Risk for Symptomatic Alzheimer Disease$389,794
P01 · FY2022 · AG · contact PI
Fluid Biomarker Core$320,530
P01 · FY2022 · AG · contact PI
Dominantly Inherited Alzheimer Network: Project 3$804,703
U19 · FY2021 · AG · contact PI
Plasma and CSF Biomarkers that Predict Risk for Symptomatic Alzheimer Disease$352,892
P01 · FY2021 · AG · contact PI
Fluid Biomarker Core$341,319
P01 · FY2021 · AG · contact PI
Dominantly Inherited Alzheimer Network: Biomarker Core$270,859
U19 · FY2021 · AG · contact PI
Dominantly Inherited Alzheimer Network: Project 3$363,601
U19 · FY2020 · AG · contact PI
Dominantly Inherited Alzheimer Network: Biomarker Core$198,311
U19 · FY2020 · AG · contact PI
Dominantly Inherited Alzheimer Network: Project 3$416,181
U19 · FY2019 · AG · contact PI
Dominantly Inherited Alzheimer Network: Biomarker Core$216,354
U19 · FY2019 · AG · contact PI
Project 1: Correlation of Tau PET Imaging with CSF AD Biomarkers$169,477
P50 · FY2019 · AG · contact PI
Project 1: Correlation of Tau PET Imaging with CSF AD Biomarkers$166,378
P50 · FY2018 · AG · contact PI
Project 1: Correlation of Tau PET Imaging with CSF AD Biomarkers$163,470
P50 · FY2017 · AG · contact PI
Project 1: Correlation of Tau PET Imaging with CSF AD Biomarkers$171,313
P50 · FY2016 · AG · contact PI
Biomarker Core$292,448
P01 · FY2015 · AG · contact PI
CSF Biomarkers of Antecedent AD$261,169
P01 · FY2015 · AG · contact PI
Project 1: Correlation of Tau PET Imaging with CSF AD Biomarkers$169,275
P50 · FY2015 · AG · contact PI
DIAN Biomarker Core$842,932
UF1 · FY2014 · AG · contact PI
Biomarker Core$300,890
P01 · FY2014 · AG · contact PI
CSF Biomarkers of Antecedent AD$268,646
P01 · FY2014 · AG · contact PI
Biomarker$169,540
U19 · FY2014 · AG · contact PI
Biomarker Core$300,517
P01 · FY2013 · AG · contact PI
CSF Biomarkers of Antecedent AD$268,273
P01 · FY2013 · AG · contact PI
Biomarker$122,772
U19 · FY2013 · AG · contact PI
Biomarker Core$32,107
P01 · FY2013 · AG · contact PI
CSF Biomarkers of Antecedent AD$27,813
P01 · FY2013 · AG · contact PI
Biomarker Core$241,159
P01 · FY2012 · AG · contact PI
CSF Biomarkers of Antecedent AD$208,916
P01 · FY2012 · AG · contact PI
Biomarker$139,449
U19 · FY2012 · AG · contact PI
Biomarker Core$284,472
P01 · FY2011 · AG · contact PI
CSF Biomarkers of Antecedent AD$234,484
P01 · FY2011 · AG · contact PI
Biomarker$158,753
U19 · FY2010 · AG · contact PI
CSF BIOMARKERS OF ANTECEDENT AD$330,899
P01 · FY2009 · AG · contact PI
Biomarker$141,106
U01 · FY2009 · AG · contact PI
CSF BIOMARKERS OF ANTECEDENT AD$342,353
P01 · FY2008 · AG · contact PI
Biomarker$124,554
U01 · FY2008 · AG · contact PI
CSF BIOMARKERS OF ANTECEDENT AD$255,925
P01 · FY2007 · AG · contact PI
CSF BIOMARKERS OF ANTECEDENT AD$143,857
P01 · FY2006 · AG · contact PI
CSF BIOMARKERS OF ANTECEDENT AD$142,519
P01 · FY2005 · AG
EFFECTS OF AGING &PGP ON AB EFFLUX FROM THE BRAIN$76,500
R03 · FY2005 · AG
EFFECTS OF AGING &PGP ON AB EFFLUX FROM THE BRAIN$76,500
R03 · FY2004 · AG
FUNCTIONAL ANALYSIS OF ASTROCYTE DERIVED APOE3 AND APOE4$98,701
K01 · FY2002 · AG
FUNCTIONAL ANALYSIS OF ASTROCYTE DERIVED APOE3 AND APOE4$96,456
K01 · FY2001 · AG
FUNCTIONAL ANALYSIS OF ASTROCYTE DERIVED APOE3 AND APOE4$85,499
K01 · FY2000 · AG